RNA viruses continue to pose formidable challenges to global public health because their compact genomes, elevated mutation rates, and capacity to hijack cellular machinery facilitate rapid adaptation, cross-species transmission, and escape from therapeutic pressure and immune defenses. A curated Research Topic published in Frontiers in Genetics brings together investigations addressing viral comparative genetics, functional dynamics, pathogenicity, and targeted therapeutic strategies. While the resulting collection is compact, spanning four distinct studies, it highlights how genome-scale methodologies interrogate viral and host RNA biology, demonstrating both the significant analytical opportunities and the methodological limitations inherent in modern data-driven discovery.
Metagenomic sequencing strategies demonstrated the capacity to detect viral genomes without relying on prior clinical assumptions in an investigation by Vazzana and colleagues. The researchers evaluated the case of a six-month-old infant admitted with severe acute hepatitis of unknown etiology, whose extensive clinical workup had yielded entirely negative results across standard virological, metabolic, genetic, and autoimmune diagnostic panels. Employing shotgun metagenomic sequencing of plasma combined with sequence-independent single-primer amplification for sequence enrichment, the investigators successfully recovered the complete 9,187-base-pair genome of human pegivirus 1 at a mean sequencing coverage depth of approximately 447-fold, with no other infectious pathogen detected.
Phylogenetic examination of the recovered human pegivirus 1 genome assigned the isolate to a distinct branch within genotype 1, exhibiting close evolutionary relationships to previously documented viral strains identified in Thailand and Denmark. Genetic analysis further identified two highly conserved amino acid substitutions situated within the non-structural protein NS3. The pediatric patient subsequently recovered following supportive care alone, leading the study authors to emphasize that viral genomic identification in plasma does not substantiate direct disease causation, particularly within a single isolated case lacking longitudinal viral-load quantitation, though it reopens discussions regarding the debated pathogenic potential of the virus.
Host transcriptional responses provide complementary diagnostic utility during acute arboviral illness, as demonstrated in an analysis conducted by Bai and collaborators focused on Chikungunya virus infection. Addressing the ongoing lack of approved vaccines or targeted antiviral therapeutics, as well as the diagnostic window where conventional reverse-transcription polymerase chain reaction and serological assays frequently miss early infection stages, the researchers re-analyzed publicly available whole-blood RNA-sequencing datasets to establish whether circular RNAs could function as reliable early diagnostic biomarkers.
Within an initial discovery cohort comprising thirty-nine acute Chikungunya patients and twenty healthy control subjects, the authors defined a distinct circular RNA signature consisting of thirteen candidates, comprising nine upregulated and four downregulated circular transcripts. To translate these findings into a practical metric, the researchers synthesized the expression values into a weighted diagnostic algorithm designated as the CHIKV-index. When evaluated within an independent pediatric validation cohort encompassing forty-three children, the index accurately separated acute infection samples from convalescent samples, achieving an area under the receiver operating characteristic curve of 0.94.
Statistical evaluation of the circular RNA profile revealed that the composite index correlated significantly with circulating viral load, though it showed no direct correlation with clinical disease severity. Functional enrichment analysis indicated that the host response involved myeloid activation and cytokine signaling pathways, with multiple parental genes corresponding to interferon-stimulated genes such as ZNFX1 and PARP12. The researchers acknowledged critical analytical limitations, noting that the complete diagnostic discrimination observed in the initial discovery cohort represented an in-sample calculation that was likely optimistic, while validation depended on comparisons between acute and convalescent stages within the same individuals rather than comparisons against uninfected cohorts or related arboviral infections.
Expanding the evaluation of non-coding transcriptomics beyond systemic viral infections, Lin and colleagues investigated the tissue-level regulatory dynamics of chronic wounds by sequencing skin samples from patients suffering from diabetic foot ulcers. Seeking to determine how long non-coding RNAs intersect with the anemia frequently accompanying chronic ulceration, the investigators performed comparative RNA sequencing between diabetic foot ulcer tissue and control tissues obtained from individuals with acute surgical wounds.
Transcriptomic profiling of the ulcer biopsies revealed twenty-one differentially expressed long non-coding RNAs, among which one transcript was upregulated and twenty were downregulated, alongside 368 differentially expressed messenger RNAs. Pathway enrichment analyses demonstrated substantial involvement of biological processes governing iron uptake and cellular transport, oxidative stress responses, and neutrophil degranulation cascades. Network analysis additionally identified the long non-coding transcript LINC02397 as an interconnected regulatory hub, though the authors noted that the exploratory findings were derived from a limited cohort of eight individuals and require prospective functional validation.
The regulatory complexity of RNA biology was further illustrated by He and colleagues through epitranscriptomic profiling of N6-methyladenosine modifications in endometriosis. Utilizing an N6-methyladenosine microarray to compare ectopic endometrial tissues against normal endometrium, the investigators identified 8,333 aberrantly methylated transcripts. Subsequent topological network analysis prioritized fifteen central hub genes, which were integrated with public databases, receiver operating characteristic curve evaluations, and quantitative reverse-transcription polymerase chain reaction assays on patient tissue specimens.
Computational drug-repurposing algorithms and molecular docking simulations conducted on the prioritized targets identified VCAM1 and RAP1A as primary candidate genes, highlighting several prospective small-molecule compounds for exploratory investigation. The researchers cautioned, however, that array profiling was restricted by a small clinical sample size, the confirmatory quantitative reverse-transcription polymerase chain reaction measured transcript abundance rather than direct site-specific methylation levels, and the pharmacological interactions were derived exclusively through computational docking algorithms.
Cross-cutting analysis of the four investigations underscores common methodological trajectories uniting modern RNA virology and cellular transcriptomics. Each contribution illustrates the power of hypothesis-free, data-driven frameworks, utilizing unbiased metagenomic genome recovery or comprehensive profiling of circular, long non-coding, and methylated RNA species to characterize clinical states when pathogenic targets or regulatory pathways remain undefined. Non-coding RNAs and epitranscriptomic marks shape the exact cellular environments in which RNA viruses replicate, suggesting that similar profiling workflows could be applied directly to investigate co-regulated viral and host transcriptomes in infected tissues.
The collective findings also demonstrate the substantial experimental gap separating candidate identification from definitive biological mechanisms. Editorial reviewers Elena Criscuolo and Alfredo Berzal-Herranz noted that primary conclusions across the studies—including viral disease causation, biomarker diagnostic generalizability, and predicted drug interactions—cannot yet be confirmed due to limited cohort sizes and reliance on computational associations. Rigorous study designs pairing hypothesis-free discovery with functional infection models, molecular perturbation assays, and independent clinical validation will be essential to translate genomic RNA observations into validated antiviral and therapeutic targets.
Subject of Research: Genomic sequencing, host non-coding RNA profiling, and epitranscriptomic analysis in viral infections and inflammatory diseases
Article Title: Editorial: RNA viruses: from molecular mechanisms to novel therapeutic targeting strategies
Article References: Criscuolo, E., & Berzal-Herranz, A. (2026). Editorial: RNA viruses: from molecular mechanisms to novel therapeutic targeting strategies. Frontiers in Genetics, 17, Article 2051642. https://doi.org/10.3389/fgene.2026.2051642
Image Credits: AI Generated
DOI: 10.3389/fgene.2026.2051642
Keywords: RNA viruses, human pegivirus 1, chikungunya virus, circular RNA, long non-coding RNA, m6A methylation, metagenomics, host-pathogen interactions, epitranscriptomics, biomarkers, pediatric hepatitis, diabetic foot ulcers, endometriosis, interferon-stimulated genes, transcriptomics, molecular mechanisms, viral life cycle
News Source: Kristina Jarvis. (November 12, 2026). Unbiased RNA Profiling Identifies Preliminary Disease Candidates Requiring Functional Validation. Scienmag.



